Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

86,510 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
May 25, 2026	UnitedHealthcare	Tzield (Teplizumab-Mzwv) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-TZIELD-CS	New policy
May 25, 2026	UnitedHealthcare	Trogarzo (Ibalizumab-Uiyk) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-TROGARZO-IBALIZUMAB-UIYK-CS	New policy
May 25, 2026	UnitedHealthcare	Tremfya (Guselkumab) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-TREMFYA-CS	New policy
May 25, 2026	UnitedHealthcare	Treatment of Temporomandibular Joint DisordersPayerPolicy · UHC-COMM-MD-TMJ-DISORDERS-CS	New policy
May 25, 2026	UnitedHealthcare	Transcranial Magnetic Stimulation for Treating Physical Health ConditionsPayerPolicy · UHC-COMM-MD-TRANSCRANIAL-MAGNETIC-STIMULATION-CS	New policy
May 25, 2026	UnitedHealthcare	Transcatheter Procedures for Heart Valve ConditionsPayerPolicy · UHC-COMM-MD-TRANSCATHETER-HEART-VALVE-PROCEDURES-CS	New policy
May 25, 2026	UnitedHealthcare	Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the LiverPayerPolicy · UHC-COMM-MD-TRANSARTERIAL-RADIOEMBOLIZATION-CS	New policy
May 25, 2026	UnitedHealthcare	Total Artificial Disc Replacement for the SpinePayerPolicy · UHC-COMM-MD-TOTAL-ARTIFICIAL-DISC-REPLACEMENT-SPINE-CS	New policy
May 25, 2026	UnitedHealthcare	Tocilizumab – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-TOCILIZUMAB-CS	New policy
May 25, 2026	UnitedHealthcare	Tezspire (Tezepelumab-Ekko) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-TEZSPIRE-CS	New policy
May 25, 2026	UnitedHealthcare	Testosterone Replacement or Supplementation Therapy – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-TESTOSTERONE-REPLACEMENT-SUPPLEMENTATION-THERAPY-CS	New policy
May 25, 2026	UnitedHealthcare	Tepezza (Teprotumumab-Trbw) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-TEPEZZA-CS	New policy
May 25, 2026	UnitedHealthcare	Synagis (Palivizumab) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SYNAGIS-PALIVIZUMAB-CS	New policy
May 25, 2026	UnitedHealthcare	Surgical and Ablative Procedures for Venous Insufficiency and Varicose VeinsPayerPolicy · UHC-COMM-MD-SURGICAL-ABLATIVE-PROCEDURES-VENOUS-INSUFFICIENCY-VARICOSE-VEINS-CS	New policy
May 25, 2026	UnitedHealthcare	Surgery of the ShoulderPayerPolicy · UHC-COMM-MD-SURGERY-SHOULDER-CS	New policy
May 25, 2026	UnitedHealthcare	Surgery of the KneePayerPolicy · UHC-COMM-MD-SURGERY-KNEE-CS	New policy
May 25, 2026	UnitedHealthcare	Surgery of the HipPayerPolicy · UHC-COMM-MD-SURGERY-HIP-CS	New policy
May 25, 2026	UnitedHealthcare	Surgery of the Hand or WristPayerPolicy · UHC-COMM-MD-SURGERY-OF-THE-HAND-OR-WRIST-AAA09CC04F	New policy
May 25, 2026	UnitedHealthcare	Surgery of the FootPayerPolicy · UHC-COMM-MD-SURGERY-FOOT-CS	New policy
May 25, 2026	UnitedHealthcare	Surgery of the ElbowPayerPolicy · UHC-COMM-MD-SURGERY-ELBOW-CS	New policy
May 25, 2026	UnitedHealthcare	Surgery for the Prevention and Treatment of LymphedemaPayerPolicy · UHC-COMM-MD-SURGICAL-TREATMENT-LYMPHEDEMA-CS	New policy
May 25, 2026	UnitedHealthcare	Subcutaneous Implantable Naltrexone Pellets – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SUBCUTANEOUS-IMPLANTABLE-NALTREXONE-PELLETS-CS	New policy
May 25, 2026	UnitedHealthcare	Stereotactic Body Radiation Therapy and Stereotactic RadiosurgeryPayerPolicy · UHC-COMM-MD-STEREOTACTIC-BODY-RADIATION-THERAPY-RADIOSURGERY-CS	New policy
May 25, 2026	UnitedHealthcare	Spinraza (Nusinersen) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SPINRAZA-NUSINERSEN-CS	New policy
May 25, 2026	UnitedHealthcare	Spinal Fusion and DecompressionPayerPolicy · UHC-COMM-MD-SPINAL-FUSION-DECOMPRESSION-CS	New policy
May 25, 2026	UnitedHealthcare	Spinal Fusion and Bone Healing Enhancement ProductsPayerPolicy · UHC-COMM-MD-SPINAL-FUSION-ENHANCEMENT-PRODUCTS-CS	New policy
May 25, 2026	UnitedHealthcare	Spevigo (Spesolimab-Sbzo) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SPEVIGO-CS	New policy
May 25, 2026	UnitedHealthcare	Somatostatin Analogs – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SOMATOSTATIN-ANALOGS-CS	New policy
May 25, 2026	UnitedHealthcare	Sodium Hyaluronate – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SODIUM-HYALURONATE-CS	New policy
May 25, 2026	UnitedHealthcare	Sleep StudiesPayerPolicy · UHC-COMM-MD-SLEEP-STUDIES-CS	New policy
May 25, 2026	UnitedHealthcare	Skyrizi (Risankizumab-Rzaa) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SKYRIZI-CS	New policy
May 25, 2026	UnitedHealthcare	Skin and Soft Tissue SubstitutesPayerPolicy · UHC-COMM-MD-SKIN-SOFT-TISSUE-SUBSTITUTES-CS	New policy
May 25, 2026	UnitedHealthcare	Sinus Surgeries and InterventionsPayerPolicy · UHC-COMM-MD-SINUS-SURGERIES-INTERVENTIONS-CS	New policy
May 25, 2026	UnitedHealthcare	Simponi Aria (Golimumab) Injection for Intravenous Infusion – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SIMPONI-ARIA-GOLIMUMAB-INJECTION-INTRAVENOUS-INFUSION-CS	New policy
May 25, 2026	UnitedHealthcare	Sensory Integration Therapy and Auditory Integration TrainingPayerPolicy · UHC-COMM-MD-SENSORY-INTEGRATION-THERAPY-AUDITORY-INTEGRATION-TRAINING-CS	New policy
May 25, 2026	UnitedHealthcare	Self-Administered Medications – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SELF-ADMINISTERED-MEDICATIONS-CS	New policy
May 25, 2026	UnitedHealthcare	Scenesse (Afamelanotide) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SCENESSE-CS	New policy
May 25, 2026	UnitedHealthcare	Saphnelo (Anifrolumab-Fnia) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-SAPHNELO-CS	New policy
May 25, 2026	UnitedHealthcare	Sacral Nerve Stimulation for Urinary and Fecal IndicationsPayerPolicy · UHC-COMM-MD-SACRAL-NERVE-STIMULATION-CS	New policy
May 25, 2026	UnitedHealthcare	Ryplazim (Plasminogen, Human-Tvmh) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-RYPLAZIM-CS	New policy
May 25, 2026	UnitedHealthcare	Roctavian (Valoctocogene Roxaparvovec-Rvox) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-ROCTAVIAN-CS	New policy
May 25, 2026	UnitedHealthcare	RNA-Targeted Therapies (Amvuttra and Onpattro) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-RNA-TARGETED-THERAPIES-CS	New policy
May 25, 2026	UnitedHealthcare	Rituximab (Riabni, Rituxan, Ruxience, & Truxima) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-RITUXAN-RITUXIMAB-CS	New policy
May 25, 2026	UnitedHealthcare	Rhinoplasty and Other Nasal ProceduresPayerPolicy · UHC-COMM-MD-RHINOPLASTY-OTHER-NASAL-SURGERIES-CS	New policy
May 25, 2026	UnitedHealthcare	Review at Launch for New to Market Medications – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-REVIEW-AT-LAUNCH-NEW-TO-MARKET-MEDICATIONS-CS	New policy
May 25, 2026	UnitedHealthcare	Respiratory Pathogen Nucleic Acid Detection TestingPayerPolicy · UHC-COMM-MD-RESPIRATORY-PATHOGEN-NUCLEIC-ACID-CS	New policy
May 25, 2026	UnitedHealthcare	Respiratory Interleukins – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-RESPIRATORY-INTERLEUKINS-CS	New policy
May 25, 2026	UnitedHealthcare	Repository Corticotropin Injections – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-REPOSITORY-CORTICOTROPIN-INJECTION-HP-ACTHAR-GEL-CS	New policy
May 25, 2026	UnitedHealthcare	Rebyota (Fecal Microbiota, Live-Jslm) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-REBYOTA-CS	New policy
May 25, 2026	UnitedHealthcare	Reblozyl (Luspatercept-Aamt) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-REBLOZYL-CS	New policy